Role of mono‑ADP‑ribosylation histone modification (Review)
- Authors:
- Jing-Jing Zha
- Yi Tang
- Ya-Lan Wang
-
Affiliations: Pathological Department, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing 400016, P.R. China - Published online on: March 31, 2021 https://doi.org/10.3892/etm.2021.10009
- Article Number: 577
-
Copyright: © Zha et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Verma M, Maruvada P and Srivastava S: Epigenetics and cancer. Genes Dev. 18:2315–2335. 2016. | |
|
Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G and Lakshmanan M: Role of novel histone modifications in cancer. Oncotarget. 9:11414–11426. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang R, Xin M, Li Y, Zhang P and Zhang M: The functions of histone modification enzymes in cancer. Curr Protein Pept Sci. 17:438–45. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Füllgrabe J, Kavanagh E and Joseph B: Histone onco-modifications. Oncogene. 30:3391–403. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Feijs KL, Verheugd P and Lüscher B: Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology. FEBS J. 280:3519–3529. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Verheugd P, Forst AH, Milke L, Herzog N, Feijs KL, Kremmer E, Kleine H and Lüscher B: Regulation of NF-kappaB signalling by the mono-ADP-ribosyltransferase ARTD10. Nat Commun. 4(1683)2013.PubMed/NCBI View Article : Google Scholar | |
|
Jwa M and Chang PE: PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein response. Nat Cell Biol. 14:1223–1230. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kistemaker HAV, Nardozza AP, Overkleeft HS, van der Marel GA, Ladurner AG and Filippov DV: Synthesis and macrodomain binding of Mono-ADP-Ribosylated peptides. Angew Chem Int Ed Engl. 55:10634–10638. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hottiger MO: ADP-ribosylation of histones by ARTD1: An additional module of the histone code? FEBS Lett. 585:1595–1599. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Posavec Marjanović M, Crawford K and Ahel I: PARP, transcription and chromatin modeling. Semin Cell Dev Biol. 63:102–113. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Ling F, Tang Y, Li M, Li QS, Li X, Yang L, Zhao W, Jin CC, Zeng Z, Liu C, et al: Mono-ADP-ribosylation of histone 3 at arginine-117 promotes proliferation through its interaction with P300. Oncotarget. 8:72773–72787. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Verdone L, La Fortezza M, Ciccarone F, Caiafa P, Zampieri M and Caserta M: Poly(ADP-Ribosyl)ation affects histone acetylation and transcription. PLoS One. 10(e0144287)2015.PubMed/NCBI View Article : Google Scholar | |
|
Kassner I, Andersson A, Fey M, Tomas M, Ferrando-May E and Hottiger MO: SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress. Open Biol. 3(120173)2013.PubMed/NCBI View Article : Google Scholar | |
|
Tikoo K, Lau SS and Monks TJ: Histone H3 phosphorylation is coupled to poly-(ADP-ribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells. Mol Pharmacol. 60:394–402. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Mareike B, Laura E, Patricia V and Bernhard L: Intracellular Mono-ADP-ribosylation in signaling and disease. Cells. 4:569–595. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Girolamo MD and Fabrizio G: The ADP-Ribosyl-transferases diphtheria toxin-like (ARTDs) family: An overview. Challenges. 9(24)2018. | |
|
Sadakierska-Chudy A and Filip MG: A comprehensive view of the epigenetic landscape. Part II: Histone post-translational modification, nucleosome level, and chromatin regulation by ncRNAs. Neurotox Res. 27:172–197. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Carter-O'Connell I and Cohen MS: Identifying direct protein targets of poly-ADP-ribose polymerases (PARPs) using engineered PARP variants-orthogonal nicotinamide adenine dinucleotide (NAD+) analog pairs. Curr Protoc Chem Biol. 7:121–139. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang S, Xue X, Pharmacy SO and University CP: PARP family and clinically used PARP Inhibitors. Guangdong Chemical Industry. 46:134–136. 2019.(In Chinese). | |
|
Pinto AF and Schüler H: Comparative structural analysis of the putative mono-ADP-ribosyltransferases of the ARTD/PARP family. Curr Top Microbiol Immunol. 384:153–166. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Loseva O, Jemth AS, Bryant HE, Schüler H, Lehtiö L, Karlberg T and Helleday T: PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA. J Biol Chem. 285:8054–8060. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Krska D, Ravulapalli R, Fieldhouse RJ, Lugo MR and Merrill AR: C3larvin Toxin, an ADP-ribosyltransferase from Paenibacillus larvae. J Biol Chem. 290:1639–1653. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Prisilla A and Chellapandi P: Structure, function and evolution of clostridium botulinum C2 and C3 toxins: Insight to poultry and veterinary vaccines. Curr Protn Pept. 18:412–424. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Li S and Zheng W: Mammalian sirtuins SIRT4 and SIRT7. Prog Mol Biol Transl Sci. 154:147–168. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Rahnasto-Rilla M, Lahtela-Kakkonen M and Moaddel R: Sirtuin 6 (SIRT6) activity assays. Methods Mol Biol. 1436:259–269. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Xinxin QI and Li S: Sirtuin family and its biological characteristics. Acta Med Sin, 2016. | |
|
Balaiya S, Abu-Amero KK, Kondkar AA and Chalam KV: Sirtuins expression and their role in retinal diseases. Oxid Med Cell Longev. 2017(3187594)2017.PubMed/NCBI View Article : Google Scholar | |
|
MacPherson L, Tamblyn L, Rajendra S, Bralha F, McPherson JP and Matthews J: 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation. Nuclc Acids Res. 41:1604–1621. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Feijs K: Characterization of the mono-ADP-ribosylation by ARTD10: Substrates, consequences and reversibility. Hochschulbibliothek der Rheinisch-Westfälischen Technischen Hochschule Aachen, 2012. | |
|
Grundy GJ, Polo LM, Zeng Z, Rulten S, Hoch NC, Paomephan P, Xu YQ, Sweet SM, Thorne AW, Oliver AW, et al: PARP3 is a sensor of nicked nucleosomes and monoribosylates histone H2B(Glu2). Nat Commun. 7(12404)2016.PubMed/NCBI View Article : Google Scholar | |
|
Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P and Verdin E: Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem. 282:33583–33592. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Rezazadeh S, Yang D, Biashad SA, Firsanov D and Gorbunova V: SIRT6 mono-ADP ribosylates KDM2A to locally increase H3K36me2 at DNA damage sites to inhibit transcription and promote repair. Aging. 12:11165–11184. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Hassa PO, Haenni SS, Elser M and Hottiger MO: Nuclear ADP-ribosylation reactions in mammalian cells: Where are we today and where are we going? Microbiol Mol Biol Rev. 70:789–829. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Ogata N, Ueda K, Kagamiyama H and Hayaishi O: ADP-ribosylation of histone H1. Identification of glutamic acid residues 2, 14, and the COOH-terminal lysine residue as modification sites. J Biol Chem. 255:7616–7620. 1980.PubMed/NCBI | |
|
Ushiroyama T, Tanigawa Y, Tsuchiya M, Matsuura R, Ueki M, Sugimoto O and Shimoyama M: Amino acid sequence of histone H1 at the ADP-ribose-accepting site and ADP-ribose X histone-H1 adduct as an inhibitor of cyclic-AMP-dependent phosphorylation. Eur J Biochem. 151:173–177. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Riquelme PT, Burzio LO and Koide SS: ADP ribosylation of rat liver lysine-rich histone in vitro. J Biol Chem. 254:3018–3028. 1979.PubMed/NCBI | |
|
Ogata N, Ueda K and Hayaishi O: ADP-ribosylation of histone H2B. Identification of glutamic acid residue 2 as the modification site. J Biol Chem. 255:7610–7615. 1980.PubMed/NCBI | |
|
Rakhimova A, Ura S, Hsu DW, Wang HY, Pears CJ and Lakin ND: Site-specific ADP-ribosylation of histone H2B in response to DNA double strand breaks. Sci Rep. 7(43750)2017.PubMed/NCBI View Article : Google Scholar | |
|
Golderer G and Gröbner P: ADP-ribosylation of core histones and their acetylated subspecies. Biochem J. 277:607–610. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Dan MB: European geosciences union general assembly. Nuclc Acids Res. 38:6350–6362. 2016. | |
|
Kleine H, Poreba E, Lesniewicz K, Hassa PO, Hottiger MO, Litchfield DW, Shilton B and Lüscher B: Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell. 32:57–69. 2008.PubMed/NCBI View Article : Google Scholar | |
|
García-Salcedo JA, Gijón P, Nolan DP, Tebabi P and Pays E: A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei. EMBO J. 22:5851–5862. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Graves DJ, Huiatt TW, Zhou H, Huang HY and Mcmahon KK: Regulatory role of arginine-specific mono(ADP-Ribosyl)transferase in muscle cells. Adv Exp Med Biol. 419:305–313. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Schwab CJ, Colville MJ, Fullerton AT and Mcmahon KK: Evidence of endogenous mono-ADP-ribosylation of cardiac proteins via anti-ADP-ribosylarginine immunoreactivity. Proc Soc Exp Biol Med. 223:389–396. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Meyer T and Hilz H: Production of anti-(ADP-ribose) antibodies with the aid of a dinucleotide-pyrophosphatase-resistant hapten and their application for the detection of mono(ADP-ribosyl)ated polypeptides. Eur J Biochem. 155:157–165. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Osago H, Terashima M, Hara N, Yamada K and Tsuchiya M: A new detection method for arginine-specific ADP-ribosylation of protein-a combinational use of anti-ADP-ribosylarginine antibody and ADP-ribosylarginine hydrolase. J Biochem Biophys Methods. 70:1014–1019. 2008.PubMed/NCBI View Article : Google Scholar | |
|
van der Heden van Noort GJ: Chemical tools to study protein ADP-ribosylation. ACS Omega. 5:1743–1751. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu Q, Marel GAVD and Filippov DV: Chemical ADP-ribosylation: Mono-ADPr-peptides and oligo-ADP-ribose. Organ Biomol Chem. 17:5460–5474. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Moyle PM and Muir TW: Method for the synthesis of mono-ADP-ribose conjugated peptides. J Am Chem Soc. 132:15878–15880. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Vivelo CA and Leung AK: Proteomics approaches to identify mono-(ADP-ribosyl)ated and poly(ADP-ribosyl)ated proteins. Proteomics. 15:203–217. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Lu AZ, Abo R, Ren Y, Gui B, Mo JR, Blackwell D, Wigle T, Keilhack H and Niepel M: Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation. Biochem Pharmacol. 168:97–106. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Han W, Li X and Fu X: The macro domain protein family: Structure, functions, and their potential therapeutic implications. Mutat Res. 727:86–103. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Feijs KLH, Forst AH, Verheugd P and Lüscher B: Macrodomain-containing proteins: Regulating new intracellular functions of mono(ADP-ribosyl)ation. Nat Rev Mol Cell Biol. 14:443–451. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Forst AH, Karlberg T, Herzog N, Thorsell AG, Gross A, Feijs KL, Verheugd P, Kursula P, Nijmeijer B, Kremmer E, et al: Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8 macrodomains. Structure. 21:426–475. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Osago H, Yamada K, Shibata T, Yoshino KI, Hara N and Tsuchiya M: Precursor ion scanning and sequencing of arginine-ADP-ribosylated peptide by mass spectrometry. Anal Biochem. 393:248–254. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Perkins DN, Pappin DJC, Creasy DM and Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567. Electrophoresis. 20:3551–3567. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Lam AT and Zhang Y: A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases. Anal Biochem. 543:132–139. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Leutert M, Bilan V, Gehrig P and Hottiger MO: Identification of ADP-ribose acceptor sites on in vitro modified proteins by liquid chromatograph-tandem mass spectrometry. Methods Mol Biol. 1608:137–148. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Larsen SC, Leutert M, Bilan V, Martello R, Jungmichel S, Young C, Hottiger MO and Nielsen ML: Proteome-wide identification of in vivo ADP-ribose acceptor sites by liquid chromatography-tandem mass spectrometry. Methods Mol Biol. 1608:149–162. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Daniels CM, Ong SE and Leung AK: Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl)ation sites from cells. J Proteome Res. 13:3510–3522. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Morgan RK and Cohen MS: A clickable aminooxy probe for monitoring cellular ADP-ribosylation. ACS Chem Biol. 10:1778–1784. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Messner S and Hottiger MO: Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol. 21:534–542. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Karch KR, Langelier MF, Pascal JM and Garcia BA: The nucleosomal surface is the main target of histone ADP-ribosylation in response to DNA damage. Mol Biosys. 13:2660–2671. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Adamietz P and Rudolph A: ADP-ribosylation of nuclear proteins in vivo. Identification of histone H2B as a major acceptor for mono- and poly(ADP-ribose) in dimethyl sulfate-treated hepatoma AH 7974 cells. J Biol Chem. 259:6841–6846. 1984.PubMed/NCBI | |
|
Kreimeyer A, Adamietz P and Hilz H: Alkylation-induced mono(ADP-ribosyl)-histones H1 and H2B. Hydroxylamine-resistant linkage in hepatoma cells. Biol Chem. 366:537–544. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Kreimeyer A, Wielckens K, Adamietz P and Hilz H: DNA repair-associated ADP-ribosylation in vivo. Modification of histone H1 differs from that of the principal acceptor proteins. J Biol Chem. 259:890–896. 1984.PubMed/NCBI | |
|
Rulten SL, Fisher AEO, Robert I, Zuma MC, Rouleau M, Ju LM, Poirier G, Reina-San-Martin B and Caldecott KW: PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol Cell. 41:33–45. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Boulikas T: DNA strand breaks alter histone ADP-ribosylation. Proc Natl Acad Sci USA. 86:3499–3503. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Boulikas T: Poly(ADP-ribosylated) histones in chromatin replication. J Biol Chem. 265:14638–14647. 1990.PubMed/NCBI | |
|
Boulikas T: Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review). Anticancer Res. 11:489–527. 1991.PubMed/NCBI | |
|
Zhang NN, Lin T, Xiao M, Li QS, Li X, Yang L, Wang CL and Wang YL: Transcriptome sequencing analysis of monoADPribosylation in colorectal cancer cells. Oncol Rep. 43:1413–1428. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Böhm L, Schneeweiss FA, Sharan RN and Feinendegen LE: Influence of histone acetylation on the modification of cytoplasmic and nuclear proteins by ADP-ribosylation in response to free radicals. Biochim Biophys Acta. 1334:149–154. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Tang Y, Li Q, Xiao M, Yang Y and Wang Y: Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2. Oncogene. 38:3488–3503. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Tanny JC, Dowd GJ, Huang J, Hilz H and Moazed D: An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell. 99:735–45. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Michan S and Sinclair D: Sirtuins in mammals: Insights into their biological function. Biochem J. 404:1–13. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Laing S, Unger M, Koch-Nolte F and Haag F: ADP-ribosylation of arginine. Amino Acids. 41:257–69. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Stevens LA, Kato J, Kasamatsu A, Oda H, Lee DY and Moss J: The ARH and macrodomain families of α-ADP-ribose-acceptor hydrolases catalyze α-NAD+ hydrolysis. ACS Chem Biol. 14:2576–2584. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Thomas A, Deeksha M, Kerryanne C, Luca P, Andreja M and Ivan A: MacroD1 is a promiscuous ADP-Ribosyl hydrolase localized to mitochondria. Front Microbiol. 9(20)2018.PubMed/NCBI View Article : Google Scholar | |
|
Abplanalp J, Leutert M, Frugier E, Nowak K, Feurer R, Kato J, Kistemaker HVA, Filippov DV, Moss J, Caflisch A and Hottiger MO: Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase. Nat Commun. 8(2055)2017.PubMed/NCBI View Article : Google Scholar | |
|
Fehr AR, Channappanavar R, Jankevicius G, Fett C, Zhao J, Athmer J, Meyerholz DK, Ahel I and Perlman S: The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection. mBio. 7:e01721–16. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Eckei L, Krieg S, Bütepage M, Lehmann A, Gross A, Lippok BE, Grimm AR, Kümmerer BM, Rossetti G, Lüscher B and Verheugd P: The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases. Sci Rep. 7(41746)2017.PubMed/NCBI View Article : Google Scholar | |
|
Li C, Debing Y, Jankevicius G, Neyts J, Ahel I, Coutard B and Canard B: Viral macro domains reverse protein ADP-ribosylation. J Virol. 90:8478–8486. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Alhammad YMO, Kashipathy MM, Roy A, Gagné JP, McDonald P, Gao P, Nonfoux L, Battaile KP, Johnson DK, Holmstrom ED, et al: The SARS-CoV-2 conserved macrodomain is a highly efficient ADP-ribosylhydrolase enzyme. bioRxiv: 2020.05.11.089375, 2020. | |
|
Munnur D and Ahel I: Reversible mono-ADP-ribosylation of DNA breaks. FEBS J. 284:4002–4016. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Scarpa ES, Fabrizio G and Di Girolamo M: A role of intracellular mono-ADP-ribosylation in cancer biology. FEBS J. 280:3551–3562. 2013.PubMed/NCBI View Article : Google Scholar |
